Fig. 2From: Effect of imatinib on plasma glucose concentration in subjects with chronic myeloid leukemia and gastrointestinal stromal tumorChange in fasting plasma glucose concentration after treatment with imatinib in subjects with normal fasting glucose, impaired fasting glucose and type 2 diabetes mellitusBack to article page